IRIS PubliCatt

Petrucci, Giovanna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.497
NA - Nord America 1.283
AS - Asia 369
OC - Oceania 12
AF - Africa 11
SA - Sud America 6
Continente sconosciuto - Info sul continente non disponibili 3
Totale 3.181
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.270
DE - Germania 456
SE - Svezia 290
IT - Italia 279
CN - Cina 213
UA - Ucraina 130
IE - Irlanda 79
SG - Singapore 68
FR - Francia 63
GB - Regno Unito 62
RU - Federazione Russa 41
IN - India 33
TR - Turchia 29
FI - Finlandia 27
CZ - Repubblica Ceca 21
BE - Belgio 19
CA - Canada 12
AU - Australia 11
AT - Austria 9
CI - Costa d'Avorio 8
IR - Iran 8
NL - Olanda 6
ES - Italia 5
KR - Corea 4
PH - Filippine 4
CH - Svizzera 3
EG - Egitto 3
NO - Norvegia 3
PK - Pakistan 3
AR - Argentina 2
BG - Bulgaria 2
EU - Europa 2
IQ - Iraq 2
YE - Yemen 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BO - Bolivia 1
BR - Brasile 1
CL - Cile 1
DK - Danimarca 1
EC - Ecuador 1
ID - Indonesia 1
JP - Giappone 1
MX - Messico 1
NZ - Nuova Zelanda 1
RO - Romania 1
SA - Arabia Saudita 1
Totale 3.181
Salva come PNG Salva come JPEG
Città #
Chandler 289
Ashburn 142
Dublin 75
San Mateo 74
Jacksonville 68
Nanjing 56
Cattolica 55
Ann Arbor 53
Rome 50
Wilmington 46
Milan 37
Moscow 33
Dearborn 29
Singapore 27
Woodbridge 26
Boston 25
Nürnberg 25
Princeton 24
New York 21
Bremen 20
Brno 20
Hounslow 20
Nanchang 20
Houston 19
Izmir 18
Bareggio 17
Lawrence 17
Redwood City 17
Brussels 14
Fairfield 14
Redmond 13
Shenyang 13
Beijing 12
Hebei 11
Kunming 11
Tianjin 11
Verona 11
Seattle 10
Busto Arsizio 9
Chicago 9
Lancaster 9
Los Angeles 9
Abidjan 8
Augusta 8
Mountain View 8
Zhengzhou 8
Bursa 7
Hangzhou 7
Jinan 7
Vienna 7
Marseille 6
Shanghai 6
Andover 5
Boardman 5
Catania 5
Chieti 5
Leawood 5
Munich 5
Guangzhou 4
North York 4
Pune 4
Quezon City 4
Toronto 4
Washington 4
Avon 3
Changchun 3
Detroit 3
Falls Church 3
Gent 3
Helsinki 3
Kish 3
Lanzhou 3
Padova 3
Prineville 3
Sacramento 3
Salò 3
Sceaux 3
Simi Valley 3
Alcalá De Henares 2
Ardabil 2
Boydton 2
Brisbane 2
Cambridge 2
Changsha 2
Civitavecchia 2
Colombes 2
Damietta 2
Edinburgh 2
Fremont 2
Istanbul 2
Jiaxing 2
Karachi 2
Latham 2
London 2
Menlo Park 2
Montréal 2
Naples 2
Norwalk 2
Nuremberg 2
Orange 2
Totale 1.691
Salva come PNG Salva come JPEG
Nome #
Qualitative and quantitative modifications of von willebrand factor in patients with essential thrombocythemia and controlled platelet count 265
Obesity is associated with in vivo platelet activation and impaired responsiveness to once-daily, low-dose aspirin 136
The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low-dose aspirin in patients with and without diabetes 129
Different STAT-3 and STAT-5 phosphorylation discriminates among Ph-negative chronic myeloproliferative diseases and is independent of the V617F JAK-2 mutation. 128
Prostaglandin E2 differentially modulates human platelet function through the prostanoid EP2 and EP3 receptors 116
Aspirin-insensitive thromboxane biosynthesis in essential thrombocythemia is explained by accelerated renewal of the drug target 113
In vivo platelet activation and aspirin responsiveness in type 1 diabetes mellitus 111
Phosphorylated STAT5 represents a new possible prognostic marker in Hodgkin lymphoma. 108
Abnormal megakaryopoiesis and platelet function in cyclooxygenase-2-deficient mice 105
Patient-independent variables affecting the assessment of aspirin responsiveness by serum thromboxane measurement 103
A randomized, double-blind trial of three aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia 100
In Vivo Platelet Activation and Aspirin Responsiveness in Type 1 Diabetes 99
Pseudo-acquired vWD in essential thrombocythemia: the role of platelets 98
Aspirin, stroke and drug-drug interactions 82
Patient-independent variables affecting the assessment of aspirin responsiveness by serum thromboxane measurement 82
Phosphorylated STAT5 represents a new possible prognostic marker in Hodgkin lymphoma 70
On-pump Cardiac Surgery Enhances Platelet Renewal and Impairs Aspirin Pharmacodynamics: Effects of Improved Dosing Regimens 70
The Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design: Implementation of the serum thromboxane B(2) assay as an evaluation tool of different aspirin dosing regimens in the clinical setting 68
Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: impact on mediators and mechanisms of the inflammatory response 65
Preoperative psychological characteristics affecting mid-term outcome after bariatric surgery: a follow-up study 64
The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy 61
Stability of urinary thromboxane A2 metabolites and adaptation of the extraction method to small urine volume 61
Aspirin inhibits cancer stem cells properties and growth of glioblastoma multiforme through Rb1 pathway modulation 59
Tumorigenic potential of olfactory bulb-derived human adult neural stem cells associates with activation of TERT and NOTCH1. 58
In vivo thromboxane-dependent platelet activation is persistently enhanced in subjects with impaired glucose tolerance 58
Aspirin inhibits proliferation and promotes differentiation of neuroblastoma cells via p21Waf1 protein up-regulation and Rb1 pathway modulation. 58
Association of Platelet Thromboxane Inhibition by Low-Dose Aspirin With Platelet Count and Cytoreductive Therapy in Essential Thrombocythemia 53
Inhibition of telomerase in the endothelial cells disrupts tumor angiogenesis in glioblastoma xenografts 49
On-pump Cardiac Surgery Enhances Platelet Renewal and Impairs Aspirin Pharmacodynamics: Effects of Improved Dosing Regimens 49
influence of local environment on the differentiation of neuronal stem cells engrafted onto the injured spinal cord 48
Pathophysiology of Thrombosis in Peripheral Artery Disease 46
Mesenchymal differentiation of glioblastoma stem cells 44
Variability in the Responsiveness to Low-Dose Aspirin: Pharmacological and Disease-Related Mechanisms. 43
Very-low-dose twice-daily aspirin maintains platelet inhibition and improves haemostasis during dual-antiplatelet therapy for acute coronary syndrome 41
Increased von Willebrand factor levels in polycythemia vera and phenotypic differences with essential thrombocythemia 41
Personalized medicine, pharmacogenetics, and clopidogrel: unraveling variability of response 40
Effect of low-dose and standard-dose aspirin on PGE2 biosynthesis among individuals with colorectal adenomas: A randomized clinical trial 39
Role of Oxidative Stress in the Pathogenesis of Atherothrombotic Diseases 33
Influence of local environment on the differentiation of neural stem cells engrafted onto the injured spinal cord 33
Mesenchymal differentiation of glioblastoma stem cells 28
Aspirin-insensitive thromboxane biosynthesis in essential thrombocythemia is explained by accelerated renewal of the drug target 27
Obesity is associated with impaired responsiveness to once-daily low-dose aspirin and in vivo platelet activation 26
Establishing tumor cell lines from aggressive telomerase-positive chordomas of the skull base: Technical note 25
Role of Oxidative Stress in the Pathogenesis of Atherothrombotic Diseases 23
Platelet thromboxane inhibition by low-dose aspirin in polycythemia vera: Ex vivo and in vivo measurements and in silico simulation 20
Physiologically based modelling of the antiplatelet effect of aspirin: A tool to characterize drug responsiveness and inform precision dosing 16
In vivo thromboxane-dependent platelet activation is persistently enhanced in subjects with impaired glucose tolerance 14
Effect of very long-term storage and multiple freeze and thaw cycles on 11-dehydro-thromboxane-B2 and 8-iso-prostaglandin F2α, levels in human urine samples by validated enzyme immunoassays 14
Physiologically based modelling of the antiplatelet effect of aspirin: A tool to characterize drug responsiveness and inform precision dosing 13
Thromboxane biosynthesis and future events in diabetes: the ASCEND trial 9
Pathophysiology of Thrombosis in Peripheral Artery Disease 5
Thromboxane biosynthesis in cancer patients and its inhibition by aspirin: a sub-study of the Add-Aspirin trial 4
Totale 3.250
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.789
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.789
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020325 0 0 42 18 30 28 49 14 15 28 72 29
2020/2021332 17 64 9 25 38 13 35 11 35 13 51 21
2021/2022390 40 18 5 24 30 10 10 85 14 19 59 76
2022/2023808 105 116 69 118 61 89 26 70 100 18 22 14
2023/2024507 15 108 19 58 44 46 31 16 15 25 51 79
2024/202558 28 24 6 0 0 0 0 0 0 0 0 0
Totale 3.250